Clinical trial
HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection
NCT00476723 · The HIV Netherlands Australia Thailand Research Collaboration, Other · Completed
Key facts
| NCT number | NCT00476723 |
|---|---|
| Title | HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection |
| Official title | Generation of HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection Receiving HBV-active Antiretroviral Therapy |
| Lead sponsor | The HIV Netherlands Australia Thailand Research Collaboration, Other |
| Collaborators | Kirby Institute Ministry of Health, Thailand |
| Status | Completed |
| Study type | Observational |
| Conditions | HIV, Hepatitis-B |
| Enrollment | 36 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | May 22, 2007 |
| Last update posted | Jun 7, 2010 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: